Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001180469-07-000009
Filing Date
2007-05-25
Accepted
2007-05-25 10:17:27
Documents
1
Period of Report
2007-05-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 42048
  Complete submission text file 0001180469-07-000009.txt   43900
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address RELIANT PHARMACEUTICALS, LLC 110 ALLEN ROAD LIBERTY CORNER NJ 07938
Business Address (908)580-1200
MARIO ERNEST (Reporting) CIK: 0001180469 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 07878896